Other languages OncoZenge AB

Equities

ONCOZ

SE0015504097

Market Closed - Nasdaq Stockholm Other stock markets 08:59:40 10/05/2024 pm IST			5-day change	1st Jan Change
3.955 ^SEK	+2.20%		+2.99%	+27.99%

08/04	Oncozenge AB Appoints Paolo Bossi as Member of the Advisory Board	CI
04/04	OncoZenge Announces Read-Out of Positive Stability Data for BupiZenge	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oncozenge AB Appoints Paolo Bossi as Member of the Advisory Board	08/04
OncoZenge Announces Read-Out of Positive Stability Data for BupiZenge	04/04
Oncozenge Explores Strategic Options for Bupizeng in China	11/03
OncoZenge AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	15/02
OncoZenge Seeks to Expand Patent Protection for Oral Lozenge Product BupiZenge	07/02
OncoZenge AB Files Patent Application for Strengthened IP Protection for BupiZenge	07/02
OncoZenge Seeks Priority Medicines Status for Oral Pain Treatment in Europe	02/01
Oncozenge Announces Formation of Advisory Board with Stephen Sonis and Pooja Nandwani Patel	13/12
Ensysce Biosciences and OncoZenge Announce Letter of Intent for the Co-Development of BupiZenge in the United States	28/11
Oncozenge AB Confirms the New Formulation of Oncozenge's Drug Candidate Bupizenge?? Is Clean	21/11
OncoZenge AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	31/23/31
Oncozenge AB Appoints Stian Kildal as New CEO	12/23/12
OncoZenge AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	31/23/31
OncoZenge AB Reports Earnings Results for the First Quarter Ended March 31, 2023	16/23/16
OncoZenge AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	14/23/14
OncoZenge AB Reports Earnings Results for the Full Year Ended December 31, 2022	14/23/14
OncoZenge AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15
OncoZenge AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16
OncoZenge AB Reports Earnings Results for the First Quarter Ended March 31, 2022	17/22/17
OncoZenge AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	15/22/15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages OncoZenge AB

Equities

ONCOZ

SE0015504097

Other languages

Filters